Lana Pepdjonovic1, Guan Hee Tan2,3, Sean Huang4, Sarah Mann4, Mark Frydenberg4,5, Daniel Moon4, Uri Hanegbi4, Adam Landau4, Ross Snow4, Jeremy Grummet4,3,5. 1. Australian Urology Associates, Melbourne, VIC, Australia. lanapep@gmail.com. 2. Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. 3. Department of Urology, Alfred Health, Melbourne, VIC, Australia. 4. Australian Urology Associates, Melbourne, VIC, Australia. 5. Department of Surgery, Monash University, Melbourne, VIC, Australia.
Abstract
PURPOSE: To determine the rate of hospital admissions for infection after transperineal biopsy of prostate (TPB) with single-dose cephazolin prophylaxis using a prospective database. METHOD: Between April 2013 and February 2016, 577 patients undergoing TPB had 2 g of cephazolin given intravenously at induction of anaesthesia. Data collected from these patients included age, PSA, prostate volume, number of cores taken and post-operative complications. RESULTS: No patients were readmitted to hospital with infection post-TPB. Seven patients developed acute urinary retention, and one patient developed clinical prostatitis that was treated with oral antibiotics in the community. CONCLUSION: It is safe to use single-dose cephazolin only as antibiotic prophylaxis prior to TPB, negating the need for quinolones. This study supports Australia's current Therapeutic Guidelines recommendation for TPB prophylaxis and the existing evidence that sepsis post-TPB is a rare complication. Whether any antibiotic prophylaxis is needed at all for TPB is the subject of a future study.
PURPOSE: To determine the rate of hospital admissions for infection after transperineal biopsy of prostate (TPB) with single-dose cephazolin prophylaxis using a prospective database. METHOD: Between April 2013 and February 2016, 577 patients undergoing TPB had 2 g of cephazolin given intravenously at induction of anaesthesia. Data collected from these patients included age, PSA, prostate volume, number of cores taken and post-operative complications. RESULTS: No patients were readmitted to hospital with infection post-TPB. Seven patients developed acute urinary retention, and one patient developed clinical prostatitis that was treated with oral antibiotics in the community. CONCLUSION: It is safe to use single-dose cephazolin only as antibiotic prophylaxis prior to TPB, negating the need for quinolones. This study supports Australia's current Therapeutic Guidelines recommendation for TPB prophylaxis and the existing evidence that sepsis post-TPB is a rare complication. Whether any antibiotic prophylaxis is needed at all for TPB is the subject of a future study.
Authors: J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer Journal: J Urol Date: 2008-02-20 Impact factor: 7.450
Authors: Jeremy P Grummet; Mahesha Weerakoon; Sean Huang; Nathan Lawrentschuk; Mark Frydenberg; Daniel A Moon; Mary O'Reilly; Declan Murphy Journal: BJU Int Date: 2014-02-19 Impact factor: 5.588
Authors: Lona Vyas; Peter Acher; Janette Kinsella; Ben Challacombe; Richard T M Chang; Paul Sturch; Declan Cahill; Ashish Chandra; Richard Popert Journal: BJU Int Date: 2014-04-03 Impact factor: 5.588
Authors: Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod Journal: J Urol Date: 2013-01 Impact factor: 7.450
Authors: Despina Kotsanas; W R P L I Wijesooriya; Tony M Korman; Elizabeth E Gillespie; Louise Wright; Kylie Snook; Natalie Williams; Jan M Bell; Hua Y Li; Rhonda L Stuart Journal: Med J Aust Date: 2013-03-18 Impact factor: 7.738
Authors: Matthew J Roberts; Alastair Macdonald; Sachinka Ranasinghe; Harrison Bennett; Patrick E Teloken; Patrick Harris; David Paterson; Geoff Coughlin; Nigel Dunglison; Rachel Esler; Robert A Gardiner; Thomas Elliott; Louisa Gordon; John Yaxley Journal: Prostate Cancer Prostatic Dis Date: 2020-08-05 Impact factor: 5.554
Authors: Kevin Martell; Hans Chung; Gerard Morton; Danny Vesprini; Chia-Lin Tseng; Ewa Szumacher; Patrick Cheung; Will Chu; Stanley Liu; Andrew Loblaw Journal: Can Urol Assoc J Date: 2022-08 Impact factor: 2.052
Authors: K Günzel; A Magheli; E Baco; H Cash; S Heinrich; H Neubert; J Schlegel; M Schostak; T Henkel; P Asbach; S Hinz Journal: World J Urol Date: 2021-04-18 Impact factor: 4.226